ALNY - Alnylam Pharmaceuticals Inc

$16.85 -0.10 | -0.59%
Today's Range: 16.56 - 16.93
ALNY Avg. Daily Volume: 92,826
12/17/09 - 11:25 AM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 16.95
52 Week High 26.36
52 Week Low 14.82
Avg. Daily Vol. (Mil) 0.24
Beta (3 year) 0.82
Share Related Items
Mkt Cap (Mil) 708.77
Shares Out (Mil) 41.82
Float (Mil) 41.19
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.20
Current Ratio 2.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 7.21
Price/Book 3.89
Price/Cash Flow -16.70
Per Share Data
Earnings -1.19
Sales 2.35
Book Value 4.35
Cash Flow -1.02
Business Summary
A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.
General Information
300 Third Street
Cambridge, MA 02142
www.alnylam.com
Industry : Drugs
Sector: Health Care
Employees: 170
CEO: Dr. John M. Maraganore,
Short Interest
Current Month (Mil) 4.69
Previous Month (Mil) 5.21
Short Interest Ratio (Days) 14.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -9.90
Return on Investments -27.00
Profitability
Gross Margin n.a.
EBIT Margin -48.70
Profit Margin -50.00
Latest ALNY Headlines

Brokerage Partners

TheStreet Premium Services

All Services